{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:51:04Z","timestamp":1791838264264,"version":"4.3.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>The proton pump inhibitors (PPIs) are extensively prescribed for the empirical treatment of epigastric pain and heartburn in cancer patients. However, they carry the potential for drug interactions with antineoplastic agents during active cancer therapy, and osteopenia, opportunistic infections, adverse cardiovascular outcomes, and altered gut microbiome in long-term users in survivorship. Herein, we examined the use of endoscopy with esophageal 96-hour ambulatory pH monitoring in guiding clinicians in safely prescribing PPI in 21 such patients. We retrospectively studied patients with active cancer or in survivorship, presenting with PPI-refractory heartburn. All underwent an endoscopy with esophageal ambulatory pH monitoring performed \u201coff\u201d PPI therapy for 96\u00a0hours, following a \u201cliberal diet\u201d for the first 48, and a \u201crestrictive diet\u201d for the latter 48\u00a0hours. Acid exposure time (AET)\u2009\u2265\u20096% per 24\u00a0hours was defined as abnormal. For each patient, the average AET from the first 2\u00a0days was considered as baseline and was compared with that from the latter 2\u00a0days (on restrictive diet). We concluded that ambulatory 96-hour pH monitoring, identifies 48% of patients with normal AET, who may not need PPI. Esophageal pH monitoring on restrictive diet normalizes AET in 73% of patients, thereby allowing esophageal acid control to be achieved with diet\u00a0alone.<\/jats:p>","DOI":"10.1093\/dote\/doaf102","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:19:12Z","timestamp":1763576352000},"source":"Crossref","is-referenced-by-count":2,"title":["Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-3773","authenticated-orcid":false,"given":"George","family":"Triadafilopoulos","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition, UT MD Anderson Cancer Center , Houston TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"5","key":"2025111913190972000_ref1","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S1470-2045(20)30069-3","article-title":"Clinical implications of food\u2013drug interactions with small-molecule kinase inhibitors","volume":"21","author":"Veerman","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6161","key":"2025111913190972000_ref2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"science."},{"issue":"6","key":"2025111913190972000_ref3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jamaoncol.2016.3323","article-title":"Drug-drug interactions with oral antineoplastic agents","volume":"3","author":"Parsad","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025111913190972000_ref4","doi-asserted-by":"publisher","first-page":"1758835918818347","DOI":"10.1177\/1758835918818347","article-title":"Clinically relevant drug interactions with multikinase inhibitors: a review","volume":"11","author":"Hussaarts","year":"2019","journal-title":"Ther Adv MedOncol"},{"issue":"7634","key":"2025111913190972000_ref5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"2025111913190972000_ref6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"2025111913190972000_ref7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ijc.31529","article-title":"Proton pump inhibitor use and cancer mortality","volume":"143","author":"Tvingsholm","year":"2018","journal-title":"Int J Cancer"},{"issue":"8","key":"2025111913190972000_ref8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/10428194.2023.2216324","article-title":"Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study","volume":"64","author":"Vilmar","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2025111913190972000_ref9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/gut.25.9.957","article-title":"Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity","volume":"25","author":"Sharma","year":"1984","journal-title":"Gut"},{"issue":"6","key":"2025111913190972000_ref10","doi-asserted-by":"publisher","first-page":"e2113739","DOI":"10.1001\/jamanetworkopen.2021.13739","article-title":"Prevalence of proton pump inhibitor use among patients with cancer","volume":"4","author":"Raoul","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2025111913190972000_ref11","doi-asserted-by":"publisher","first-page":"716317","DOI":"10.3389\/fimmu.2021.716317","article-title":"Impact of antibiotics and proton pump inhibitors on efficacy and tolerance of anti-PD-1 immune checkpoint inhibitors","volume":"12","author":"Giordan","year":"2021","journal-title":"Front Immunol"},{"issue":"157","key":"2025111913190972000_ref12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejca.2021.08.036","article-title":"Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events","volume":"157","author":"Kostine","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"2025111913190972000_ref13","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.esmoop.2023.100880","article-title":"Drug\u2013drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure","volume":"8","author":"Raoul","year":"2023","journal-title":"ESMO open"},{"key":"2025111913190972000_ref14","doi-asserted-by":"publisher","first-page":"102794","DOI":"10.1016\/j.ctrv.2024.102794","article-title":"Proton pump inhibitors and cancer treatments: emerging evidence against coadministration","volume":"129","author":"Raoul","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"2025111913190972000_ref15","doi-asserted-by":"publisher","first-page":"doac102","DOI":"10.1093\/dote\/doac102","article-title":"Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet","volume":"36","author":"Triadafilopoulos","year":"2023","journal-title":"Dis Esophagus"},{"issue":"5","key":"2025111913190972000_ref16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1442-2050.2012.01381.x","article-title":"Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy","volume":"26","author":"Galindo","year":"2013","journal-title":"Dis Esophagus"},{"issue":"7","key":"2025111913190972000_ref17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon consensus","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"},{"issue":"8","key":"2025111913190972000_ref18","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s10620-019-05940-9","article-title":"Ninety-six hour wireless Esophageal pH study in patients with GERD shows that restrictive diet reduces Esophageal acid exposure","volume":"65","author":"Triadafilopoulos","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2025111913190972000_ref19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gut.2005.072629","article-title":"Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring","volume":"54","author":"Bredenoord","year":"2005","journal-title":"Gut"},{"issue":"6","key":"2025111913190972000_ref20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"issue":"10","key":"2025111913190972000_ref21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/apt.14986","article-title":"Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease","volume":"48","author":"Ribolsi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2025111913190972000_ref22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.gtc.2021.08.004","article-title":"Functional chest pain and Esophageal hypersensitivity: a clinical approach","volume":"50","author":"Bhardwaj","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"issue":"8683","key":"2025111913190972000_ref23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms in gastro-oesophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"2025111913190972000_ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox069","article-title":"Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading","volume":"30","author":"Capovilla","year":"2017","journal-title":"Dis Esophagus"},{"issue":"2","key":"2025111913190972000_ref25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41366-024-01525-3","article-title":"The past, present, and future of behavioral obesity treatment","volume":"49","author":"Chao","year":"2025","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"2025111913190972000_ref26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"2025111913190972000_ref27","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10620-018-5183-4","article-title":"Use of Esophageal pH monitoring to minimize proton-pump inhibitor utilization in patients with gastroesophageal reflux symptoms","volume":"63","author":"Triadafilopoulos","year":"2018","journal-title":"Dig Dis Sci"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/6\/doaf102\/65396964\/doaf102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/6\/doaf102\/65396964\/doaf102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:19:13Z","timestamp":1763576353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doaf102\/8328286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doaf102","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,1]]},"article-number":"doaf102"}}